Real-World Research on Retinal Diseases Using Health Claims Database: A Narrative Review

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2024 Jul 27

PMID 39061705

Authors

Seong Joon Ahn

Affiliations

Soon will be listed here.

Abstract

Real-world data (RWD) has emerged as a crucial component in understanding and improving patient outcomes across various medical conditions, including retinal diseases. Health claims databases, generated from healthcare reimbursement claims, offer a comprehensive source of RWD, providing insights into patient outcomes, healthcare utilization, and treatment effectiveness. However, the use of these databases for research also presents unique challenges. This narrative review explores the role of real-world research on retinal diseases using health claims databases, highlighting their advantages, limitations, and potential contributions to advancing our understanding and management of the diseases. The review examines the applications of health claims databases in retinal disease research, including epidemiological studies, comparative effectiveness and safety analyses, economic burden assessments, and evaluations of patient outcomes and quality of care. Previous findings demonstrate the value of these databases in generating prevalence and incidence estimates, identifying risk factors and predictors, evaluating treatment effectiveness and safety, and understanding healthcare utilization patterns and costs associated with retinal diseases. Despite their strengths, health claims databases face challenges related to data limitations, biases, privacy concerns, and methodological issues. Accordingly, the review also explores future directions and opportunities, including advancements in data collection and analysis, integration with electronic health records, collaborative research networks and consortia, and the evolving regulatory landscape. These developments are expected to enhance the utility of health claims databases for retinal disease research, resulting in more comprehensive and impactful findings across diverse retinal disorders and robust real-world insights from a large population.

References

Lewallen S, Courtright P . Epidemiology in practice: case-control studies. Community Eye Health. 2007; 11(28):57-8. PMC: 1706071. View

Daien V, Eldem B, Talks J, Korobelnik J, Mitchell P, Finger R . Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources. BMC Ophthalmol. 2019; 19(1):206. PMC: 6796465. DOI: 10.1186/s12886-019-1208-9. View

Penberthy L, Rivera D, Lund J, Bruno M, Meyer A . An overview of real-world data sources for oncology and considerations for research. CA Cancer J Clin. 2021; 72(3):287-300. DOI: 10.3322/caac.21714. View

Martin-Merino E, Fortuny J, Rivero-Ferrer E, Lind M, Garcia-Rodriguez L . Risk factors for diabetic retinopathy in people with Type 2 diabetes: A case-control study in a UK primary care setting. Prim Care Diabetes. 2016; 10(4):300-8. DOI: 10.1016/j.pcd.2016.01.002. View

Nguyen A, Roberts T, Ryu W, Lambert S . Endophthalmitis after pediatric cataract surgery in the United States: report using an insurance claims database. J Cataract Refract Surg. 2021; 47(9):1161-1166. PMC: 8411018. DOI: 10.1097/j.jcrs.0000000000000602. View

Shen J, Bouee S, Aris E, Emery C, Beck E . Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM). Infect Dis Ther. 2021; 11(1):249-262. PMC: 8847620. DOI: 10.1007/s40121-021-00546-z. View

Kwon H, Kim J, Ahn S . Screening practices and risk assessment for maculopathy in pentosan polysulfate users across different exposure levels. Sci Rep. 2024; 14(1):11270. PMC: 11101426. DOI: 10.1038/s41598-024-62041-y. View

McNair D, Lumpkin M, Kern S, Hartman D . Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World. Clin Pharmacol Ther. 2021; 111(1):44-51. PMC: 9298255. DOI: 10.1002/cpt.2449. View

Dharan N, Radovich T, Che S, Petoumenos K, Juneja P, Law M . HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme. BMC Public Health. 2019; 19(1):13. PMC: 6318998. DOI: 10.1186/s12889-018-6325-5. View

10.

OByrne M, DeCost G, Katcoff H, Savla J, Chang J, Goldmuntz E . Resource Utilization in the First 2 Years Following Operative Correction for Tetralogy of Fallot: Study Using Data From the Optum's De-Identified Clinformatics Data Mart Insurance Claims Database. J Am Heart Assoc. 2020; 9(15):e016581. PMC: 7792257. DOI: 10.1161/JAHA.120.016581. View

11.

Parikh R, Ross J, Sangaralingham L, Adelman R, Shah N, Barkmeier A . Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients. Ophthalmology. 2016; 124(3):352-358. DOI: 10.1016/j.ophtha.2016.10.036. View

12.

Rein D, Wittenborn J, Zhang P, Sublett F, Lamuda P, Lundeen E . The Economic Burden of Vision Loss and Blindness in the United States. Ophthalmology. 2021; 129(4):369-378. DOI: 10.1016/j.ophtha.2021.09.010. View

13.

Kim J, Kwon H, Ahn S . COVID-19 Vaccine-Associated Uveitis in Patients With a History of Uveitis. JAMA Ophthalmol. 2024; 142(6):522-528. PMC: 11046406. DOI: 10.1001/jamaophthalmol.2024.0973. View

14.

Morsanutto A, Berto P, Lopatriello S, Gelisio R, Voinovich D, Cippo P . Major complications have an impact on total annual medical cost of diabetes: results of a database analysis. J Diabetes Complications. 2006; 20(3):163-9. DOI: 10.1016/j.jdiacomp.2005.06.011. View

15.

Hong E, Shin Y, Bae G, Choi Y, Ahn S, Kim I . Ophthalmic complications in retinopathy of prematurity in the first decade of life in Korea using the national health insurance database. Sci Rep. 2022; 12(1):911. PMC: 8766475. DOI: 10.1038/s41598-021-04616-7. View

16.

Hong E, Shin Y, Bae G, Choi Y, Ahn S, Sobrin L . Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007-2018 national health insurance claims data. Sci Rep. 2021; 11(1):1451. PMC: 7809441. DOI: 10.1038/s41598-021-80989-z. View

17.

Liu J, Barrett J, Leonardi E, Lee L, Roychoudhury S, Chen Y . Natural History and Real-World Data in Rare Diseases: Applications, Limitations, and Future Perspectives. J Clin Pharmacol. 2022; 62 Suppl 2:S38-S55. PMC: 10107901. DOI: 10.1002/jcph.2134. View

18.

Ahn S, Kim J, Kwon H . Nationwide Screening Practices for Tamoxifen Retinal Toxicity in South Korea: A Population-Based Cohort Study. J Clin Med. 2024; 13(8). PMC: 11050852. DOI: 10.3390/jcm13082167. View

19.

Hsieh C, Su C, Shao S, Sung S, Lin S, Kao Yang Y . Taiwan's National Health Insurance Research Database: past and future. Clin Epidemiol. 2019; 11:349-358. PMC: 6509937. DOI: 10.2147/CLEP.S196293. View

20.

Muramatsu K, Imamura H, Tokutsu K, Fujimoto K, Fushimi K, Matsuda S . Epidemiological Study of Hospital Admissions for Food-Induced Anaphylaxis Using the Japanese Diagnosis Procedure Combination Database. J Epidemiol. 2020; 32(4):163-167. PMC: 8918617. DOI: 10.2188/jea.JE20200309. View